These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16291774)

  • 1. Pulmonary toxicity from novel antineoplastic agents.
    Dimopoulou I; Bamias A; Lyberopoulos P; Dimopoulos MA
    Ann Oncol; 2006 Mar; 17(3):372-9. PubMed ID: 16291774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-induced toxicity of the lungs: an overview.
    Charpidou AG; Gkiozos I; Tsimpoukis S; Apostolaki D; Dilana KD; Karapanagiotou EM; Syrigos KN
    Anticancer Res; 2009 Feb; 29(2):631-9. PubMed ID: 19331213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic pulmonary lesions.
    Roden AC; Camus P
    Semin Diagn Pathol; 2018 Jul; 35(4):260-271. PubMed ID: 29631763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary toxicity of drugs and thoracic irradiation in children].
    Fauroux B; Clément A; Tournier G
    Rev Mal Respir; 1996 Jul; 13(3):235-42. PubMed ID: 8765915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review.
    Lehne G; Lote K
    Acta Oncol; 1990; 29(2):113-24. PubMed ID: 2185802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary drug toxicity: radiologic and pathologic manifestations.
    Rossi SE; Erasmus JJ; McAdams HP; Sporn TA; Goodman PC
    Radiographics; 2000; 20(5):1245-59. PubMed ID: 10992015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.
    Hadjinicolaou AV; Nisar MK; Bhagat S; Parfrey H; Chilvers ER; Ostör AJ
    Rheumatology (Oxford); 2011 Dec; 50(12):2297-305. PubMed ID: 22019799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced interstitial lung diseases].
    Bonniaud P; Georges M; Favrolt N; Camus P
    Rev Prat; 2014 Sep; 64(7):951-6. PubMed ID: 25362778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of gefitinib-related interstitial lung disease: multi-institutional analysis by the West Japan Thoracic Oncology Group.
    Endo M; Johkoh T; Kimura K; Yamamoto N
    Lung Cancer; 2006 May; 52(2):135-40. PubMed ID: 16574271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced interstitial lung disease.
    Limper AH; Rosenow EC
    Curr Opin Pulm Med; 1996 Sep; 2(5):396-404. PubMed ID: 9363174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial lung disease induced by drugs and radiation.
    Camus P; Fanton A; Bonniaud P; Camus C; Foucher P
    Respiration; 2004; 71(4):301-26. PubMed ID: 15316202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced and iatrogenic infiltrative lung disease.
    Camus P; Bonniaud P; Fanton A; Camus C; Baudaun N; Foucher P
    Clin Chest Med; 2004 Sep; 25(3):479-519, vi. PubMed ID: 15331188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer.
    Yoneda KY; Shelton DK; Beckett LA; Gandara DR
    J Thorac Oncol; 2007 Jun; 2(6):537-43. PubMed ID: 17545850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
    Roubille C; Haraoui B
    Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
    Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R
    Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary toxicity of antineoplastic drugs.
    Batist G; Andrews JL
    JAMA; 1981 Sep; 246(13):1449-53. PubMed ID: 7265453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and functional disorders in side effects of drugs on the lung].
    Konietzko N
    Pneumologie; 1990 Feb; 44 Suppl 1():173-7. PubMed ID: 2195511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.
    Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
    Malik SW; Myers JL; DeRemee RA; Specks U
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1851-6. PubMed ID: 8970380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory side-effects of drugs].
    van der Drift MA; Kaajan JP
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):145-50. PubMed ID: 11845561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.